Elemene

Drug Profile

Elemene

Alternative Names: beta-Elemene; Elemene Injection; Elemene Oral Emulsion

Latest Information Update: 02 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
  • Developer BeiJing Yijiayi Medicine Techonology; Dalian Holley Kingkong Pharmaceutical
  • Class Antineoplastics; Sesquiterpenes; Small molecules
  • Mechanism of Action Apoptosis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Clinical Phase Unknown Liver cancer

Most Recent Events

  • 28 Nov 2016 Clinical trials in Liver cancer (Combination therapy, First-line therapy, Late-stage disease, Metastatic disease) in China (Injection) (NCT03166553)
  • 28 Nov 2016 Clinical trials in Liver cancer (Combination therapy, First-line therapy, Late-stage disease, Metastatic disease) in China (PO) (NCT03166553)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top